BECKHOVE; Philipp

Patent Applications and Registrations

Patent applications and USPTO patent grants for BECKHOVE; Philipp.The latest application filed is for "pharmaceutical combination of anti ceacam6 and tim3 antibodies".

Company Profile

7.3.14

BECKHOVE; Philipp - Heidelberg DE
BECKHOVE; Philipp - Regensburg DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Combination Of Anti Ceacam6 And Tim3 Antibodies App 20220089721 - WILLUDA; Jrog ; et al.	2022-03-24
Pharmaceutical Combination Of Anti-ceacam6 And Either Anti-pd-1 Or Anti-pd-l1 Antibodies For The Treatment Of Cancer App 20220010017 - WILLUDA; Jorg ; et al.	2022-01-13
Antibodies Targeting, And Other Modulators Of, An Immunoglobulin Gene Associated With Resistance Against Anti-tumour Immune Responses, And Uses Thereof App 20210061908 - BECKHOVE; Philipp ; et al.	2021-03-04
Intracellular Kinase Associated With Resistance Against Anti-tumour Immune Responses, And Uses Thereof App 20210040486 - SORRENTINO; Antonio ; et al.	2021-02-11
Modulators Of Tumor Immune Resistance For The Treatment Of Cancer App 20200164068 - KHANDELWAL; Nisit ; et al.	2020-05-28
Or10h1 Antigen Binding Proteins And Uses Thereof App 20200024347 - MEIER-EWERT; Sebastian ; et al.	2020-01-23
Cytotoxic T Cell Response Modifiers App 20200002706 - Beckhove; Philipp ; et al.	2020-01-02
Immune Modulators For Reducing Immune-resistance In Melanoma And Other Proliferative Diseases App 20190263906 - Beckhove; Philipp ; et al.	2019-08-29
Modulators Of Ccr9 For Treating Tumor Resistance To Immune Responses App 20190054110 - KHANDELWAL; Nisit ; et al.	2019-02-21
Cytotoxic T Cell Response Modifiers App 20180298388 - Beckhove; Philipp ; et al.	2018-10-18
Cytotoxic T cell response modifiers Grant 9,994,854 - Beckhove , et al. June 12, 2	2018-06-12
Cytotoxic T Cell Response Modifiers App 20160201066 - Beckhove; Philipp ; et al.	2016-07-14
Multi-modal cancer therapy using viral hitch-hiking Grant 8,142,791 - Schirrmacher , et al. March 27, 2	2012-03-27
Inhibition Of Angiogenesis And Tumor Metastasis App 20110171290 - Altevogt; Peter ; et al.	2011-07-14
Heparanase-derived peptides for vaccination of tumor patients Grant 7,842,782 - Schirrmacher , et al. November 30, 2	2010-11-30
Multi-modal Cancer Therapy Using Viral Hitch-hiking App 20100062007 - Schirrmacher; Volker ; et al.	2010-03-11
Heparanase-Derived peptides for Vaccination of Tumor patients App 20070253970 - Schirrmacher; Volker ; et al.	2007-11-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.